BENGALURU (Reuters) – The Serum Institute of India is preparing to produce Novavax’s COVID-19 vaccine in the country, government official Vinod Kumar Paul said at a press briefing on Tuesday.
The vaccine maker on Monday had said its COVID-19 vaccine was more than 90% effective in a large, late-stage U.S.-based clinical trial.
(Reporting by Shivani Singh in Bengaluru, editing by Louise Heavens)
